Juniper Pharmaceuticals Inc (JNP) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

Juniper Pharmaceuticals Inc (Juniper), formerly Columbia Laboratories Inc is a womens health therapeutic company that focuses on developing therapeutics that address unmet medical needs. It develops, manufactures, licenses and sells pharmaceutical products in womens health. The company utilizes proprietary drug delivery technologies to treat various medical conditions to commercial partners. Its proprietary technology includes intravaginal ring (IVR) and bioadhesive gel (BDS). Juniper provides a range of drug development services and consulting services to the pharmaceutical industry. The company operates in pharmaceutical industry and also provides in-house expertise for internal pharmaceutical programs. The company operates in the US, the UK, Switzerland and other countries. Juniper is headquartered in Boston, Massachusetts, the US.

Juniper Pharmaceuticals Inc (JNP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 5
List of Figures 5
Juniper Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Juniper Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Juniper Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Juniper Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Juniper Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10
Juniper Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Juniper Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Juniper Pharma Acquires Three New Products to its Proprietary Pipeline 12
Partnerships 13
Juniper Pharma Services Enters into Agreement with Crystec Pharma 13
Molecular Profiles Enters Into Co-Development Agreement With Telormedix 14
Molecular Profiles Enters Into Agreement With Onyx Scientific 15
Licensing Agreements 16
Dare Bioscience Enters into Licensing Agreement with Juniper Pharma 16
Juniper Pharma Enters into Licensing Agreement with Harvard Medical, Massachusetts General Hospital and Massachusetts Institute of Technology 18
Columbia Labs Enters into Licensing Agreement for IVR Technology 20
Asset Transactions 21
Lil Drug Store Exercises Option to Acquire Rights for Legatrin PM from Columbia Labs for USD2.2 Million 21
Acquisition 22
Catalent to Acquire Juniper Pharma 22
Columbia Labs Acquires Molecular Profiles For US$25 Million 24
Juniper Pharmaceuticals Inc - Key Competitors 25
Juniper Pharmaceuticals Inc - Key Employees 26
Juniper Pharmaceuticals Inc - Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 28
Strategy And Business Planning 28
Sep 18, 2017: Juniper Pharmaceuticals Announces Strategic Reprioritization 28
Financial Announcements 30
May 10, 2018: Juniper Pharmaceuticals Reports First Quarter 2018 Financial and Operating Results 30
Mar 08, 2018: Juniper Pharmaceuticals Reports Full-Year 2017 Financial and Operating Results 31
Nov 02, 2017: Juniper Pharmaceuticals Reports Third Quarter 2017 Financial and Operating Results 33
Aug 03, 2017: Juniper Pharmaceuticals Reports Second Quarter 2017 Financial and Operating Results 34
May 04, 2017: Juniper Pharmaceuticals Reports First Quarter 2017 Financial and Operating Results 35
Mar 07, 2017: Juniper Pharmaceuticals Reports Fourth Quarter and Full-Year 2016 Financial and Operating Results 37
Corporate Communications 39
Mar 21, 2018: Juniper Pharmaceuticals Appoints Richard Messina to Board of Directors 39
Sep 11, 2017: Juniper Pharmaceuticals Appoints Jennifer Good to Board of Directors 40
Other Significant Developments 41
Jan 31, 2018: Juniper Pharmaceuticals to Explore Strategic Alternatives 41
Jan 02, 2018: Juniper Pharma Outlines Strategic Priorities for 2018 and Reports Recent Portfolio Progress 42
Aug 08, 2017: Major Progress in Next Generation Medicines Initiative 43
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44

List Of Tables

List of Tables
Juniper Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Juniper Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Juniper Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Juniper Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Juniper Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Juniper Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10
Juniper Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Juniper Pharma Acquires Three New Products to its Proprietary Pipeline 12
Juniper Pharma Services Enters into Agreement with Crystec Pharma 13
Molecular Profiles Enters Into Co-Development Agreement With Telormedix 14
Molecular Profiles Enters Into Agreement With Onyx Scientific 15
Dare Bioscience Enters into Licensing Agreement with Juniper Pharma 16
Juniper Pharma Enters into Licensing Agreement with Harvard Medical, Massachusetts General Hospital and Massachusetts Institute of Technology 18
Columbia Labs Enters into Licensing Agreement for IVR Technology 20
Lil Drug Store Exercises Option to Acquire Rights for Legatrin PM from Columbia Labs for USD2.2 Million 21
Catalent to Acquire Juniper Pharma 22
Columbia Labs Acquires Molecular Profiles For US$25 Million 24
Juniper Pharmaceuticals Inc, Key Competitors 25
Juniper Pharmaceuticals Inc, Key Employees 26
Juniper Pharmaceuticals Inc, Subsidiaries 27

List Of Figures

List of Figures
Juniper Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Juniper Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Juniper Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Juniper Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Juniper Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Juniper Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Juniper Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Juniper Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Juniper Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10

Juniper Networks: Performance, Capabilities, Goals and Strategies in the Global Communication Equipment Industry

This report is part of the Competitive Analysis Series prepared by LeadingMarketResearch.com to help current suppliers and potential market entrants realistically assess their financial, technological and marketing capabilities in relation

USD 950 View Report

Juniper Pharmaceuticals Inc (JNP) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Juniper Pharmaceuticals Inc (Juniper), formerly Columbia Laboratories Inc is a womens health therapeutic company that focuses on developing therapeutics that address unmet medical needs. It develops, manufactures, licenses and sells

USD 250 View Report

Amneal Pharmaceuticals Inc (AMRX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Amneal Pharmaceuticals Inc (Amneal) formerly Amneal Pharmaceuticals LLC, is an integrated specialty pharmaceutical company that produces generic, specialty and biosimilar medicines. Its product portfolio includes generic and specialty drugs in

USD 250 View Report

EyePoint Pharmaceuticals Inc (PSDV) - Product Pipeline Analysis, 2018 Update

EyePoint Pharmaceuticals Inc (EyePoint), formerly pSivida Corp, is a biopharmaceutical company that provides development of miniaturized, sustained-release drug delivery products and technologies. The company offers products such as iluvien, retisert

USD 750 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available